论文部分内容阅读
目的评价东菱迪夫突击连续给药对急性脑梗死(发病12小时内)的疗效及完全性。方法凡符合入选标准的患者随机分为2组,A组:60例接受东菱迪夫10U连续3次,总量30U;B组60例接受东菱迪夫10U,隔日5U,总量20U。根据欧洲脑卒中评分判定标准及对纤维蛋白原测定评价。结果A组有效率高于B组,A组纤维蛋白原降低较B组明显,无1例梗死后出血。结论东菱迪夫30U治疗急性脑梗死完全有效。
Objective To evaluate the curative effect and completeness of Donglingdufu assault continuous administration on acute cerebral infarction (within 12 hours of onset). Methods All patients who met the inclusion criteria were randomly divided into two groups. Group A: 60 patients received Dongluidefu 10U for 3 times in a row for 30U; 60 patients in Group B received 10L Dongluidifu every other day with a total volume of 20U. According to European stroke rating criteria and evaluation of fibrinogen. Results The effective rate of group A was higher than that of group B. The decrease of fibrinogen in group A was more obvious than that of group B, and no one had postoperative bleeding. Conclusion Dongluo Di 30U is completely effective in treating acute cerebral infarction.